Overview


According to FutureWise analysis, the market for U.S. Supplemental Health is expected to grow with a CAGR of 5.70% over the forecast period 2024-2032, and reach a market value of US$ 56.2 billion by 2031.

U.S. supplemental health insurance, also known as "Medigap", is a private health insurance that helps cover the costs that Original Medicare (Part A and Part B) does not cover. Medigap policies are offered by private insurance corporations and are standardized by the federal government, which means that the benefits are the same regardless of which insurance company you choose. These policies help pay for some of the out-of-pocket costs of Medicare, such as copayments, coinsurance, and deductibles. These can also include policies that provide additional coverage for specific conditions, such as cancer or critical illness insurance, as well as policies that provide a cash benefit in the case of hospitalization or disability.

U.S. Supplemental Health insurance is used in different applications to provide additional coverage beyond what traditional health insurance plans offer. Critical Illness Insurance, for instance, offers a lump-sum payout in case of a serious illness diagnosis, helping policyholders cover expenses that may not be fully covered by their primary health insurance. Accident Insurance provides financial support in case of unexpected injuries, covering costs associated with medical treatment, rehabilitation, and other related expenses. Furthermore, Hospital Indemnity Insurance serves as a safety net by providing fixed cash benefits for hospital stays, which can be used to offset out-of-pocket costs or even cover everyday expenses during recovery. Also, Worksite Life insurance offers an added layer of protection by providing a death benefit to beneficiaries in the unfortunate event of the policyholder's passing. This can offer peace of mind to individuals who want to ensure their loved ones are financially secure in such a circumstance.

FutureWise Market Research has published a report that provides an insightful analysis U.S. supplemental health market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts U.S. supplemental health market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Aetna Inc.
  • Allianz S.E.
  • American International Group, Inc.
  • Anthem, Inc.
  • Assurant, Inc.
  • AXA Group
  • Cigna Corporation
  • Humana Inc.
  • MetLife, Inc.
  • Zurich Insurance Group AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

The rising incidence of the geriatric population is anticipated to increase the demand for the U.S. supplemental health market. As the population ages, individuals are more likely to encounter health issues, leading to an increased demand for supplemental health insurance. This is primarily because older individuals tend to have more complex healthcare needs that standard plans like Medicare or employer-sponsored insurance may not fully cover. Furthermore, the high costs of healthcare services and treatments have become a significant concern. This financial burden compels many individuals to seek additional coverage beyond their primary insurance, ensuring comprehensive protection against unexpected medical expenses. Additionally, advancements in healthcare and insurance technology present a promising avenue for the expansion of supplemental health products. Advanced technologies such as telemedicine, wearable health monitors, and data analytics are revolutionizing the way healthcare services are delivered and managed. This creates a fertile ground for innovative supplemental health offerings that may leverage these technologies to provide more personalized, efficient, and accessible care options. Also, strategic collaborations with healthcare providers and other industries might yield synergistic benefits. By partnering with hospitals, clinics, or even wellness companies, supplemental health insurers may tap into existing networks, gain valuable insights, and offer bundled solutions that enhance overall value for consumers. Therefore, it bolsters the credibility and relevance of U.S. supplemental health products and extends their market reach, ultimately propelling growth in the industry. However, healthcare policy and regulation changes may significantly hinder the U.S. supplemental health market. Alterations in government policies may introduce new compliance requirements and alter reimbursement structures, potentially leading to increased administrative burdens and costs for insurers. Moreover, shifts in consumer perspectives and behaviors regarding supplemental health insurance may present a restraint. If consumers perceive these products as less essential or opt for alternative healthcare financing options, it could lead to a decline in demand. This changing perception may be driven by factors such as economic conditions, evolving healthcare preferences, or even shifts in societal attitudes toward insurance coverage, all of which may hamper the market's growth potential.

By Product

  • Critical Illness Insurance
  • Accident Insurance
  • Hospital Indemnity Insurance
  • Worksite Life
  • Dental

By Distribution Channel

  • Direct-to-Consumer (DTC)
  • Agents
  • Brokers
  • Others

By Demography

  • Individuals Aged 65 and Above
  • Individuals Aged Below 65 with an Eligible Disability

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the U.S. Supplemental Health Market By Product, By Distribution Channel and By Demography
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  U.S. Supplemental Health Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of U.S. Supplemental Health Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  U.S. Supplemental Health Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  U.S. Supplemental Health Market, By Product Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Critical Illness Insurance
      2. Accident Insurance
      3. Hospital Indemnity Insurance
      4. Worksite Life
      5. Dental
  • 8.  U.S. Supplemental Health Market, By Distribution Channel Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Direct-to-Consumer (DTC)
      2. Agents
      3. Brokers
      4. Others
  • 9.  U.S. Supplemental Health Market, By Demography Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Individuals Aged 65 and Above
      2. Individuals Aged Below 65 with an Eligible Disability
  • 10.  Market Share Analysis and Competitive Landscape
    •   1. U.S. Landscape - Key Players, Revenue and Presence
        2. U.S. Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. U.S. Emerging Companies
        4. U.S. - Market Share Analysis and Key Regional Players
        5. U.S. Key Player - Growth Matrix

  • 11.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Aetna Inc.
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Allianz S.E.
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. American International Group, Inc.
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Anthem, Inc.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Assurant, Inc.
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. AXA Group
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Cigna Corporation
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Humana Inc.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. MetLife, Inc.
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Zurich Insurance Group AG
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview

  • 12.  Pre and Post COVID-19 Impact
    •  1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 13.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients